CCN5 regulation in ER-positive BC cells is dependent on oestrogen, insulin-like growth factor, and HIF-α2, the expression of which has been found to be involved in the control of the proliferative and invasive phenotype of these cells [14, 18, 25]. This evidence concerns the gene CCN5 and breast cancer.